---  
layout: startup_page  
title: "Endogenex"  
id: "endogenex.com"  
permalink: "/endogenexendogenex.com06252024/"  
website: "https://www.endogenex.com/"  
funding_round: "Series C"  
funding_amount: "$88M"  
investors: "Hatteras Venture Partners, Lumira Ventures, Orlando Health Ventures, undisclosed strategic lead investor, Intuitive Ventures, Longitude Capital, Mayo Clinic, Sant√© Ventures"  
about: "Endogenex is a clinical-stage medical device company focused on improving outcomes for individuals with type 2 diabetes. Their ReCET System, a novel endoscopic outpatient procedure, targets duodenal cellular pathology to initiate the body's natural regenerative process and improve metabolic function. This aims to help patients better control blood glucose levels and slow disease progression."  
markets: "Medical Device, Diabetes"  
hq: "Plymouth, Minnesota, United States"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/endogenexinc"  
twitter: "https://twitter.com/endogenex"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/dyamx"  
pitchbook: "https://pitchbook.com/profiles/company/232325-11"  

date_display: "25-Jun-2024"  
date: "2024-06-25"

# SEO Optimization  
meta_title: "Endogenex - Series C Funding ($88M)"  
meta_description: "Endogenex, Endogenex is a clinical-stage medical device company focused on improving outcomes for individuals with type 2 diabetes. Their ReCET System, a novel e..."  
meta_keywords: "Endogenex, Medical Device, Diabetes, Series C funding"  
canonical_url: "https://startup.projectstartups.com/endogenexendogenex.com06252024/"  
---